Angiogenesis Inhibitors: all 4,430 studies that test it
Page 21 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell CarcinomaCompletedNCT00083889Phase 3Results posted
- UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation ChemotherapyCompletedNCT00083551Phase 3Results posted
- Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and ThalidomideCompletedNCT00083382Phase 2Results posted
- UARK 2003-33, Total Therapy IIICompletedNCT00081939Phase 2Results posted
- Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's LymphomaCompletedNCT00081861Phase 2Results posted
- Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung CancerCompletedNCT00079040Phase 2Results posted
- A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.CompletedNCT00077974Phase 2Results posted
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)CompletedNCT00075829Phase 3Results posted
- A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)CompletedNCT00075218Phase 3Results posted
- Effectiveness of Topical Thalidomide to Treat Chronic Graft-Versus-Host-Disease Related StomatitisTerminatedNCT00075023Phase 2Results posted
- Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced CancersCompletedNCT00074308Phase 1/2Results posted
- Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00072566Phase 2Results posted
- A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal CancerCompletedNCT00069095Phase 3Results posted
- Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic AbnormalityCompletedNCT00065156Phase 2Results posted
- S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple MyelomaCompletedNCT00064038Phase 3Results posted
- CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00056160Phase 3Results posted
- Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver CancerCompletedNCT00055692Phase 2Results posted
- Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative PatientsCompletedNCT00055237Phase 2Results posted
- Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast CancerCompletedNCT00054132Phase 2Results posted
- Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple MyelomaCompletedNCT00049673Phase 3Results posted
- Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With SurgeryCompletedNCT00049322Phase 2Results posted
- Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent GliomasCompletedNCT00047879Phase 2Results posted
- Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00041080Phase 3Results posted
- S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT00040937Phase 2Results posted
- Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the UterusCompletedNCT00025506Phase 2Results posted
- Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the CervixCompletedNCT00025233Phase 2Results posted
- Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00022659Phase 2Results posted
- Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal CancerTerminatedNCT00019747Phase 2Results posted
- Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung CancerTerminatedNCT00004859Phase 3Results posted
- Thalidomide for the Treatment of Hormone-Dependent Prostate CancerCompletedNCT00004635Phase 3Results posted
- Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple MyelomaCompletedNCT00004088Phase 2Results posted
- A Trial to Evaluate the Safety and Usability of the SB15 PFS in Trial Participants With AMD, Macular Oedema Secondary to RVO, or Diabetic Macular OedemaCompletedNCT07844343Phase 2
- Laser Photocoagulation and Ranibizumab Treatment in Proliferative Diabetic RetinopathyCompletedNCT07819253Not applicable
- Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity: A Prospective Interventional Case SeriesCompletedNCT07721298Not applicable
- Bevacizumab Plus Nab-paclitaxel and Tegafur Gimeracil Oteracil Potassium Capsule (S-1) as Second-line Treatment for Advanced Biliary Tract Cancer: a Phase Ⅱ Clinical TrialCompletedNCT07719738Phase 2
- Bioequivalence Study Comparing Two Pomalidomide 4 mg Capsule Formulations in Healthy Male SubjectsCompletedNCT07694011Phase 1
- Outcomes of Intravitreal Ranibizumab Injection for Diabetic Vitreous HemorrhageCompletedNCT07690800Phase 4
- A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNVCompletedNCT07550504Phase 2
- Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic RetinopathyCompletedNCT07501052Phase 2
- A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid TumorsWithdrawnNCT07449481Phase 2
- A Study to Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)CompletedNCT07389577Phase 3
- The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective StudyCompletedNCT07272265Not applicable
- Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCHActive, not recruitingNCT07204041Phase 2
- Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic SynovitisCompletedNCT07187661Not applicable
- Real-world Study of Lenalidomide After First-line Treatment Lenvatinib With PD-1 in Advanced HCCCompletedNCT07184424Not applicable
- AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncerWithdrawnNCT07146919Phase 1/2
- Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab InjectionCompletedNCT07144865Not applicable
- High Dose Eylea for Proliferative Diabetic Retinopathy OutcomesActive, not recruitingNCT07118670Phase 4
- Intravitreal Faricimab in Patients With Refractory Macular EdemaCompletedNCT07093385Phase 2
- A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell LymphomaWithdrawnNCT07030699Phase 2
- Bevacizumab Versus Triamcinolone Acetonide for the Treatment of Keloids.Active, not recruitingNCT07014280Phase 4
- Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal CancerSuspendedNCT07011550Phase 2
- SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal CancerCompletedNCT06908031Phase 2
- Safety and Efficacy of Immunomodulator Drug Thalidomide in Multi-transfused Thalassemia PatientsCompletedNCT06888232Not applicable
- Trial of ProAgio in Advanced/Metastatic Colorectal CancerSuspendedNCT06867822Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular EdemaCompletedNCT06850922Phase 1/2
- Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal CancerCompletedNCT06843954Phase 4
- JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRCActive, not recruitingNCT06838338Phase 1
- A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU)Active, not recruitingNCT06817343Phase 1
- A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular DegenerationActive, not recruitingNCT06795048Phase 4
- A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular EdemaCompletedNCT06771271Phase 1
- A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid TumorsActive, not recruitingNCT06730750Phase 1/2
- Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff TendinopathyWithdrawnNCT06712290Not applicable
- Ocular Safety and Usability Study for FYB203 PFSCompletedNCT06708637Phase 4
- Ocular Safety and Usability Study for FYB201 PFSCompletedNCT06708624Phase 4
- Switching to Aflibercept 8mg in Patients Showing Limited Response to Previous TreatmentCompletedNCT06683950Phase 4
- Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative ChemotherapyActive, not recruitingNCT06680622Phase 2
- CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric CancerActive, not recruitingNCT06667050Phase 2
- Pomalidomide as an Immune-enhancing Agent for the Control of HIVActive, not recruitingNCT06660498Phase 1/2
- A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular DegenerationCompletedNCT06591598Phase 4
- Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid TumorsActive, not recruitingNCT06571422Phase 1
- Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in OsteosarcomaCompletedNCT06562673Phase 1/2
- IVB for Post-vitrectomy Hemorrhage in Diabetic EyesCompletedNCT06559488Not applicable
- Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Active, not recruitingNCT06547944Phase 1
- An Open-label, Uncontrolled Study of ONO-4578 and ONO-4538 in Combination With Standard-of-care Docetaxel and Ramucirumab as Second-line Therapy in Patients With Advanced or Recurrent Non-small Cell Lung CancerCompletedNCT06542731Phase 1
- The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal CancerActive, not recruitingNCT06540261Phase 1
- Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab InjectionCompletedNCT06510582Phase 1
- A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell LymphomaActive, not recruitingNCT06508658Phase 3
- Obinutuzumab, Zanubrutinib, and Lenalidomide Followed Short-Cycle of Obinutuzumab and Cytarabine in Newly Diagnosed Mantle Cell LymphomaActive, not recruitingNCT06504199Phase 2
- Long Term Beta Thalassemia Treatment: Findings From The Extension PeriodActive, not recruitingNCT06490601Phase 2
- SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract CancerActive, not recruitingNCT06465563Phase 2
- A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular EdemaCompletedNCT06422507Phase 3
- Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein OcclusionCompletedNCT06416241Phase 4
- Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell TransplantationWithdrawnNCT06348147Phase 2
- Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer PatientsTerminatedNCT06332079Phase 2
- Visual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual AcuityCompletedNCT06330220Phase 4
- Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)SuspendedNCT06329570Phase 1/2
- First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC PatientsActive, not recruitingNCT06313970Phase 2
- Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver MetastasesActive, not recruitingNCT06311851Phase 1/2
- A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular EdemaCompletedNCT06305416Phase 3
- Efficacy of Combination of Hdroxyurea and Thalidomide Over Hydroxyurea or Thalidomide in the Treatment of Transfusion Dependent Thalassemia in ChildrenCompletedNCT06299670Phase 4
- Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5Active, not recruitingNCT06284122Phase 3
- A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction CancerActive, not recruitingNCT06251973Phase 2
- A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy VolunteersCompletedNCT06232902Phase 1
- A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomideActive, not recruitingNCT06208150Phase 3
- A Study of Glofitamab and Lenalidomide in People With Mantle Cell LymphomaActive, not recruitingNCT06192888Phase 1
- Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular LymphomaActive, not recruitingNCT06191744Phase 3
- A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic MyopiaCompletedNCT06176352Phase 3
- Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT06158841Phase 3
- Thalidomide and Hydroxyurea Combination in β-Thalassemia PatientsCompletedNCT06153784Phase 2/3